SubHero Banner

Injectafer® (ferric carboxymaltose) – New indication

November 19, 2021 - The FDA approved American Regent’s Injectafer (ferric carboxymaltose), for the treatment of iron deficiency anemia (IDA) in adults and pediatric patients 1 year of age and older who have either intolerance to oral iron or an unsatisfactory response to oral iron.

Download PDF